|
|
|
| Effect of Alteplase Thrombolysis Combined With Butylphthalide on Acute Cerebral Infarction |
| Zhang Guotao, Li Dongli, Wu Jing |
| Department of Brain Ward Two, Sui County Hospital of Traditional Chinese Medicine, Shangqiu 476900, China |
|
|
|
|
Abstract Objective To investigate the therapeutic effect of alteplase thrombolysis combined with butylphthalide on acute cerebral infarction. Methods A total of 100 patients with acute cerebral infarction were selected and divided into an observation group（50 cases）and a control group（50 cases）according to the random number table method.Patients in the control group were treated with alteplase thrombolysis + conventional medications.On the basis of the control group，patients in the observation group were treated with butylphthalide for 14 days.Compare the levels of serum PTX-3，MMP-9，S100β，National Institutes of Health Stroke Scale（NIHSS）score，Montreal Cognitive Assessment Scale（MoCA）score before treatment and 14 days after treatment between the two groups.The incidence of adverse reactions during treatment was compared between the two groups. Results Compared with before treatment，the serum PTX-3，MMP-9，and S100β levels of the two groups were significantly reduced after 14 days of treatment，and the serum PTX-3，MMP-9，and S100β levels of the observation group were significantly reduced，and the difference was statistically significant（P<0.05）.Compared with before treatment，the NIHSS scores of the two groups were significantly reduced after 14 days of treatment，and the NIHSS score of the observation group decreased more significantly.Compared with before treatment，the MoCA scores of the two groups increased significantly after 14 days of treatment，and the MoCA score of the observation group increased more significantly，the difference was statistically significant（P<0.05）.There was no statistically significant difference in the incidence of adverse reactions between the two groups during treatment（P>0.05）. Conclusion On the basis of alteplase thrombolytic therapy，combined with butylphthalide in the treatment of acute cerebral infarction can effectively improve the patient's neurological and cognitive functions，the inflammatory response is reduced，and does not cause serious drug reactions，clinical treatment is safe and effective.
|
|
Received: 22 December 2020
|
|
|
|
|
|
[1] 王蕾，苏勇，肖雪野.阿替普酶急诊溶栓治疗超早期急性脑梗死的疗效观察［J].脑与神经疾病杂志，2018，26（5）：38-42.
[2] 李佳艳，王慎安，王文忠，等.急性脑梗死静脉溶栓治疗预后的影响因素［J].北京医学，2019，41（5）：379-381.
[3] 刘运平，王慧娟，曹妍，等.丁苯酞氯化钠联合依达拉奉治疗急性期脑梗死的临床疗效研究及安全性评价［J].河北医药，2015，37（22）：3411-3414.
[4] 王蔚文.临床疾病诊断与疗效判断标准［M].北京：科学技术文献出版社，2010：390-392.
[5] 贾宝，韩怀志.降纤酶对急性脑梗死患者血清超敏C反应蛋白、D-二聚体及NIHSS评分和Barthel指数的影响［J].海南医学，2016，27（18）：2945-2948.
[6] 张雪海，周少珑，张倩.急性脑梗死患者认知功能障碍危险因素及预防策略［J].中国老年学杂志，2019，39（14）：3366-3368.
[7] Liu X，Rao S，Wang J.Intravenous thrombolysis in combination with mild hypothermia therapy in the treatment of acute cerebral infarction［J].Pak J Med Sci Q，2019，35（4）：1161.
[8] 杨涌涛，金戈，李鑫，等.急性脑梗死静脉溶栓影响神经功能改善临床研究［J].中国药业，2020，29（1）：76-79.
[9] 陈娜，李虹，陆连生，等.阿替普酶静脉溶栓同时联合丁苯酞注射液治疗急性脑梗死的疗效观察［J].河北医药，2017，39（1）：69-71.
[10] 李孟修，王艳竹，任志军，等.探讨急性脑梗死采取阿替普酶静脉溶栓同时联合丁苯酞注射液治疗的效果［J].齐齐哈尔医学院学报，2019，40（19）：2402-2404. |
| [1] |
Wang Hewang. Effect of Salvia Polyphenolic Injection on Angina Pectoris Attack and Cardiac Function Indexes in Patients With Stable Angina Pectoris[J]. journal1, 2021, 41(6): 11-13. |
| [2] |
. [J]. journal1, 2021, 41(6): 67-68. |
| [3] |
. [J]. journal1, 2021, 41(6): 73-74. |
| [4] |
. [J]. journal1, 2021, 41(6): 138-139. |
| [5] |
Fan Lina. Effect of Buspirone in the Treatment of Schizophrenia and Its Influence on Cognitive Function and Quality of Life[J]. journal1, 2021, 41(6): 23-24. |
| [6] |
. [J]. journal1, 2021, 41(6): 83-84. |
|
|
|
|
2021, Vol. 41 
